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COVID-19 is a massive global economic and health calamity causing social and economic disruption at an unprecedented scale. Ironically, this large-scale disruption in anthropogenic activity has also fueled a massive downturn in consumption of fossil fuels and global reduction in air pollution. Indeed, it is widely speculated that current reductions in acute coronary syndrome admissions noted globally may relate to reduction in air pollution level, given the well-known relationship between reductions in air pollution levels and cardiovascular events. The ominously opposing trajectories, decrease in air pollution-related mortality and surge in COVID-19 deaths also reveal the eerie similarities in the flurry of public discourse regarding the utility of personalised protective equipment (PPE) to prevent exposure among the public.

Prior to the COVID-19 epidemic, there has been a vigorous debate about the efficacy of PPEs, including N95 respirators and masks, in protecting the public against air pollution risk (which is for the most part cardiovascular) and 'flattening' the shape of the air pollution exposure response curve.[@R1] Unfortunately for air pollution, there has been limited guidance for the public in terms of efficacious personal interventions. Given the large burden of disease attributable to both air pollution and now COVID-19, the public deserves rapid dissemination and adoption of personal-level strategies to prevent untoward health outcomes.

Central to a public health approach in minimising spread among the general public is to mitigate risk of exposures, not only to COVID-19 cases but also to asymptomatic carriers who may harbour the virus and thus pose a significant health risk to others. This at the moment seems to be a larger problem, given the fact that widespread testing is unavailable. While the efficacy of governmental lockdowns to minimise widespread dissemination of the virus to protect the public is highly effective in preventing spread at least in the short term, emerging data from countries such as China, Japan and South Korea suggest that other measures could also have contributed in reducing the spread. For instance, in many of these countries, the use of masks of all types was widespread prior to severe acute respiratory syndrome (SARS)-CoV2, and it is culturally and socially acceptable for the public to wear masks.

Citing lack of evidence, the Centers for Disease Control and Prevention (CDC) initially did not recommend the use of any face mask in any out of workplace setting. On 3 April 2020, citing 'new evidence', the CDC recommended wearing cloth face coverings in public settings. This is ironic because many CDC-recommended activities such as social distancing and handwashing also completely lack high levels of evidence to prevent pandemics. They were promoted because they are logical and are low/no-cost measures. While wearing a mask may not necessarily eliminate healthy people on the street from getting sick and does not replace important measures such as handwashing or social distancing, it may be considerably better than doing nothing. While studies reveal the challenge of establishing a clear benefit for handwashing, surface desensitisation, social distancing or of wearing masks, the absence of evidence is indeed not equivalent to evidence of absence.

Human corona viruses are typically about 125 nm but are often expelled as part of droplets that range from hundreds of microns down to about 10 microns. The critical size of the so-called large 'droplets' is a function of many physical parameters, such as relative humidity, the ambient air velocity and air temperature, while the trajectory and deposition of these droplets depend on the size and velocity of these particles when discharged from a patient or carrier. Previous modelling studies have suggested that large particles of \>100 micron can reach distances as far as 6 ft (the recommended gap for social distancing), when ejected via coughing or sneezing, but simple face masks could be effective with these larger particles ([figure 1](#F1){ref-type="fig"}). In contrast, smaller particles of \<10 micron can be carried for longer distances. The droplets of a typical cough expulsion have a wide size distribution, but recent studies using laser particle size analysers seem to suggest that the majority of particles are actually substantially larger than 50 microns with evidence of both unimodal and bimodal distribution of particles.[@R2] However, many studies have shown that there are substantial numbers of particles less than 2.5 micron (PM~2.5~) which contribute very little to the overall mass but could potentially contribute to viral dissemination. This situation is analogous to air pollution where the PM~2.5~ and ultrafine particles contribute significantly to particle number but only to a small fraction of the overall mass, but, owing to their deposition into the distal airway/alveoli, may exert systemic effects, including on the cardiovascular system.[@R1] In the case of SARS-CoV2, although a number of aspects of biology are unknown, a closer examination of several issues may convince most that it may be targetable using a simple mask intervention.
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N95 respirators, widely touted as likely highly effective in reducing exposure to SARS-COV2, have only been validated for usage during occupational settings, with very few speciﬁcally validated to provide protection even against ambient PM~2.5~, let alone infectious agents like SARS-CoV2. Moreover, it is widely recognised that N95 respirators made by different manufacturers have different performance efficiencies below the 0.3 micron range that are dependent on user fit and other ambient conditions. N95 respirators are uncomfortable and cannot be worn for more than a few hours at a time and are not going to be available for use by the lay public, given current supply chain issues and cost. In contrast, inexpensive face masks, such as procedural (surgical masks) or others made from cloth, cotton or gauze, are widely available, can be worn for long periods successfully, and have been historically dismissed both for protection against PM~2.5~ and viral infections as they are presumed to be ineffective in reducing exposure to particles of 2.5 micron. While it is true that the number of studies that have compared N95 masks with surgical or cloth masks in the context of air pollution and viral infections is limited, it is untrue that there is no evidence.[@R4] In a study in mannequins, disposable surgical masks were more effective than cloth masks, but N95 respirators were the most effective in removing air particles. Cloth mask performance, although unpredictable in some cases, reduced particles by 57%.[@R6] In a study in Indonesia, nine different masks were compared. Surgical masks were the only class of mask to signiﬁcantly decrease PM~2.5~, although they had a large performance range and did not improve PM~2.5~ exposure in all subjects.[@R7] This is to be expected, as a number of factors including facial seal are important determinants of efficacy of surgical masks. In another study from Europe comparing homemade cloth masks and surgical masks with N95 respirators in volunteers exposed mostly to particles in the ultrafine range (\<0.1 micron), generated by lit candles, both inward protection and outward protection (protection from transmitting to the environment) were tested during both short term (few minutes) and over several hours.[@R5] The results confirmed the superior efficacy of N95 respirators, but what was striking was the efficacy of surgical masks and homemade masks in reducing particle concentrations by 4-fold and 3-fold, respectively (compared with 100-fold by the N95 mask).[@R5] It is well known that the efficacy of masks for larger particles, particularly in the droplet range, likely the most important societal transmission mode of COVID, is substantially higher. Thus, the evidence supports the efficacy for a simple mask type intervention that may be particularly apt for the protection of caregivers not involved with direct patient care and also for the public at large, particularly in social situations that brings them in close proximity to others such as in grocery stores and restaurants.

Technically, one could quantify by how much the threefold to fourfold reduction of droplets achieved by masks may contribute to a reduction in SARS-CoV2 payload and reproduction rates, but unfortunately, this type of mathematical exercise would require a priori knowledge of a number of factors starting with the infectious load and the distribution of viral particles in large versus smaller particles, which are currently unavailable. However, a number of aspects relevant to SARS-CoV2 biology could be helpful in circumventing these limitations in understanding. Current testing for SARS-CoV2 suggests that the virus is present in large numbers in the upper respiratory tract. The receptor for SARS-CoV2 (ACE-2) is also highly expressed in the nasal epithelium and upper respiratory tract ([figure 1](#F1){ref-type="fig"}).[@R8] Given that the upper respiratory tract is the major site for SARS-Cov-2 replication and likely entry, wearing simple face masks which exert a barrier function in blocking not only large projectile droplets but also, to a lesser extent, smaller aerosols of \<10 micron, may substantially reduce the replication rate. Thus, used in combination with other measures, a simple face mask intervention may result in further flattening of the 'curve'. The lessons learnt from COVID-19 could be leveraged to reduce air pollution-related cardiovascular mortality and morbidity once this current impasse from the virus lifts, the inevitable resumption of anthropogenic activity and related fossil fuel consumption at least in the short term.
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